Hematopoietic stem cells in neonates: Any differences between very preterm and term neonates?

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wisgrill, Lukas ^a   Schüller, Simone ^a   Bammer, Markus ^a   Berger, Angelika ^a   Pollak, Arnold ^a   Radke, Teja Falk ^b   Kögler, Gesine ^b   Spittler, Andreas ^c   Helmer, Hanns ^d   Husslein, Peter ^d   Gortner, Ludwig ^e  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^e SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ATOSIBAN; BETAMETHASONE; CD133 ANTIGEN; CD34 ANTIGEN; CELL MARKER; CORTICOSTEROID; HEXOPRENALINE; STEROID; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADULT; AMNION FLUID; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CD34 SELECTION; CELL ISOLATION; CHORIOAMNIONITIS; CLONOGENESIS; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; FETUS; FEVER; FLOW CYTOMETRY; GESTATIONAL AGE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFANT; LEUKOCYTE COUNT; LEUKOCYTOSIS; LOW BIRTH WEIGHT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL DISEASE; MECONIUM PERITONITIS; MEDICAL HISTORY; MONONUCLEAR CELL; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; NEWBORN; NEWBORN DISEASE; ODOR; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURITY; PROLONGED RUPTURE OF MEMBRANE; PROTEINURIA; SMALL FOR DATE INFANT; TACHYCARDIA; TOCOLYSIS; UMBILICAL CORD BLOOD; UNIVARIATE ANALYSIS; UTERINE TENDERNESS; UTERUS DISEASE; VERY LOW BIRTH WEIGHT; BLOOD; CELL COUNT; CFU COUNTING; COMPARATIVE STUDY; CYTOLOGY; FETUS BLOOD; METABOLISM; MOTHER; PREGNANCY; TERM BIRTH;

ADULT; ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; ANTIGENS, CD34; CELL COUNT; COLONY-FORMING UNITS ASSAY; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; MOTHERS; PEPTIDES; PREGNANCY; TERM BIRTH;

EID: 84938557993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106717     Document Type: Article

References (43)

1. Gluckman E (2000) Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 28: 1197-1205.
2. Eglitis MA, Mezey E (1997) Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A 94: 4080-4085. (Pubitemid 27180502)
3. Ishikawa F, Drake CJ, Yang S, Fleming P, Minamiguchi H, et al. (2003) Transplanted human cord blood cells give rise to hepatocytes in engrafted mice. Ann N Y Acad Sci 996: 174-185. (Pubitemid 36706599)
4. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377. (Pubitemid 32455343)
5. Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, et al. (2012) Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 129: 1019-1026.
6. Kogler G, Critser P, Trapp T, Yoder M (2009) Future of cord blood for nononcology uses. Bone Marrow Transplant 44: 683-697.
7. Donega V, van Velthoven CT, Nijboer CH, van Bel F, Kas MJ, et al. (2013) Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS One 8: e51253.
8. Zhang X, Wang H, Shi Y, Peng W, Zhang S, et al. (2012) Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biol Int 36: 589-594.
9. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, et al. (2009) Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 18: 869-886.
10. Dalous J, Pansiot J, Pham H, Chatel P, Nadaradja C, et al. (2013) Use of human umbilical cord blood mononuclear cells to prevent perinatal brain injury: a preclinical study. Stem Cells Dev 22: 169-179.
11. Sun J, Allison J, McLaughlin C, Sledge L, Waters-Pick B, et al. (2010) Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion 50: 1980-1987.
12. Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, et al. (2014) Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr 164: 973-979 e971.
13. Gortner L, Felderhoff-Muser U, Monz D, Bieback K, Kluter H, et al. (2012) Regenerative therapies in neonatology: clinical perspectives. Klin Padiatr 224: 233-240.
14. Polin RA (2012) Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129: 1006-1015.
15. Fenton TR, Kim JH (2013) A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 13: 59.
16. Cervera A, Lillo R, Garcia-Sanchez F, Madero L, Madero R, et al. (2006) Flow cytometric assessment of hematopoietic cell subsets in cryopreserved preterm and term cord blood, influence of obstetrical parameters, and availability for transplantation. Am J Hematol 81: 397-410. (Pubitemid 43787925)
17. Clapp DW, Baley JE, Gerson SL (1989) Gestational age-dependent changes in circulating hematopoietic stem cells in newborn infants. J Lab Clin Med 113: 422-427. (Pubitemid 19109401)
18. Gasparoni A, Ciardelli L, Avanzini MA, Bonfichi M, di Mario M, et al. (2000) Immunophenotypic changes of fetal cord blood hematopoietic progenitor cells during gestation. Pediatr Res 47: 825-829. (Pubitemid 30365446)
19. Mohyeddin Bonab MA, Alimoghaddam KA, Goliaei ZA, Ghavamzadeh AR (2004) Which factors can affect cord blood variables? Transfusion 44: 690-693. (Pubitemid 38608245)
20. Wahid FS, Nasaruddin MZ, Idris MR, Tusimin M, Tumian NR, et al. (2012) Effects of preeclampsia on the yield of hematopoietic stem cells obtained from umbilical cord blood at delivery. J Obstet Gynaecol Res 38: 490-497.
21. Nakajima M, Ueda T, Migita M, Oue Y, Shima Y, et al. (2009) Hematopoietic capacity of preterm cord blood hematopoietic stem/progenitor cells. Biochem Biophys Res Commun 389: 290-294.
22. Lim FT, Scherjon SA, van Beckhoven JM, Brand A, Kanhai HH, et al. (2000) Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood. Am J Obstet Gynecol 183: 1144-1152.
23. Manegold G, Meyer-Monard S, Tichelli A, Pauli D, Holzgreve W, et al. (2008) Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood. Transfusion 48: 871-876. (Pubitemid 351614898)
24. Ballen KK, Wilson M, Wuu J, Ceredona AM, Hsieh C, et al. (2001) Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant 27: 7-14. (Pubitemid 32124401)
25. Hassanein SM, Amer HA, Shehab AA, Hellal MM (2011) Umbilical cord blood CD45(+)CD34(+) cells coexpression in preterm and full-term neonates: a pilot study. J Matern Fetal Neonatal Med 24: 229-233.
26. Omori A, Takahashi K, Hazawa M, Misaki N, Ohba H, et al. (2008) Maternal and neonatal factors associated with the high yield of mononuclear low-density/ CD34+ cells from placental/umbilical cord blood. Tohoku J Exp Med 215: 23-32. (Pubitemid 351791265)
27. McGuckin CP, Basford C, Hanger K, Habibollah S, Forraz N (2007) Cord blood revelations: the importance of being a first born girl, big, on time and to a young mother! Early Hum Dev 83: 733-741. (Pubitemid 350016668)
28. Baik I, Devito WJ, Ballen K, Becker PS, Okulicz W, et al. (2005) Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer. Cancer Res 65: 358-363. (Pubitemid 40070829)
29. Surbek DV, Danzer E, Steinmann C, Tichelli A, Wodnar-Filipowicz A, et al. (2001) Effect of preeclampsia on umbilical cord blood hematopoietic progenitor-stem cells. Am J Obstet Gynecol 185: 725-729. (Pubitemid 32862565)
30. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012. (Pubitemid 28007217)
31. Handgretinger R, Kuci S (2013) CD133- Positive Hematopoietic Stem Cells: From Biology to Medicine. Adv Exp Med Biol 777: 99-111.
32. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, et al. (2004) Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114: 330-338. (Pubitemid 39071605)
33. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S (2003) VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101: 168-172. (Pubitemid 36025904)
34. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, et al. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958. (Pubitemid 30062717)
35. Bailey AS, Jiang S, Afentoulis M, Baumann CI, Schroeder DA, et al. (2004) Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 103: 13-19. (Pubitemid 38029913)
36. Elkhafif N, El Baz H, Hammam O, Hassan S, Salah F, et al. (2011) CD133(+) human umbilical cord blood stem cells enhance angiogenesis in experimental chronic hepatic fibrosis. APMIS 119: 66-75.
37. Franceschini V, Bettini S, Pifferi S, Rosellini A, Menini A, et al. (2009) Human cord blood CD133+ stem cells transplanted to nod-scid mice provide conditions for regeneration of olfactory neuroepithelium after permanent damage induced by dichlobenil. Stem Cells 27: 825-835.
38. de Wynter EA, Buck D, Hart C, Heywood R, Coutinho LH, et al. (1998) CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16: 387-396. (Pubitemid 28524504)
39. Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, et al. (2004) Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104: 1648-1655. (Pubitemid 39202270)
40. Putman DM, Liu KY, Broughton HC, Bell GI, Hess DA (2012) Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury. Stem Cells 30: 2248-2260.
41. Grewal SS, Barker JN, Davies SM, Wagner JE (2003) Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 101: 4233-4244. (Pubitemid 36857783)
42. Wyrsch A, dalle Carbonare V, Jansen W, Chklovskaia E, Nissen C, et al. (1999) Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp Hematol 27: 1338-1345.
43. Kogler G, Radke TF, Lefort A, Sensken S, Fischer J, et al. (2005) Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 33: 573-583. (Pubitemid 40592174)